CLINICAL_TRIALS
trial_result
· 2022-09-16
Clinical Trial Update: Pembrolizumab vs Topotecan in Patients With Small Cell Lung Cancer [Phase 2]
Summary
Phase 2 trial comparing pembrolizumab to topotecan in small cell lung cancer was terminated with results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alliance Foundation Trials, LLC. | Conditions: Small Cell Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2022-09-16